It is thought that decreased insulin sensitivity, a cornerstone in the pathogenesis of type 2 diabetes (T2D), activates lipolysis leading to increased plasma levels of non-esterified fatty acids. This evidence concerns the gene INS and type 2 diabetes mellitus.